Safety and Efficacy of Danhong Injection Combined with Edaravone in the Treatment of Acute Cerebral Infarction:A Systematic Review
10.3870/j.issn.1004-0781.2016.07.027
- VernacularTitle:丹红注射液联合依达拉奉治疗急性脑梗死有效性及安全性系统评价
- Author:
Yan WANG
;
Nenggui XU
;
Yuehong CAO
- Publication Type:Journal Article
- Keywords:
Danhong injection;
Edaravone;
Cerebral infarction,acute;
Systematic review
- From:
Herald of Medicine
2016;35(7):780-788
- CountryChina
- Language:Chinese
-
Abstract:
Objective To assess the safety and efficacy of danhong injection combined with edaravone for acute cerebral infarction ( ACI) . Methods To search CBM、CNKI、VIP、WF、MEDLINE for randomized controlled trials ( RCTs) of related articles from inception to November 2014.After assessed the quality of studies included,RevMan5.2 software was used to analyze data. Results 23 studies,were included and 2 001 patients were involved.The results showed that the effective rate of danhong injection combined with edaravone for ACI was better than that of control group with statistical significance [ RR=1.23, 95%CI (1.17,1.29), P<0.000 01].Meta-analysis on the improvement of neurological deficit and activities of daily living also showed a better effectiveness of experimental group than control group with statistical significance [MD=-3.09,95%CI(-3.68,-2.50),P<0.000 01];[MD=15.15,95%CI(12.69,17.62), P<0.000 01].But the result showed no statistical significance in safety evaluation of two groups [RR=1.88,95%CI(0.76,4.63),P=0.17]. Conclusion Although the results support the conclusion that danhong injection with edaravone is safe and superior to either danhong injection or edaravone or conventional treatment, further large sample and high quality randomized controlled trials should be carried out.
